BOC Sciences Blog

Baicalin and baicalein can effectively inhibit SARS-CoV-2

Baicalin and baicalein can effectively inhibit SARS-CoV-2

Coronavirus type 2 of severe acute respiratory syndrome (SARS-cov-2) causes coronavirus disease (COVID-19) in humans and there is no cure. In the fight against COVID-19 epidemic, traditional Chinese medicine (TCM) […]

US clinical trials prove that remdesivir is effective in treating COVID-19!

US clinical trials prove that remdesivir is effective in treating COVID-19!

COVID-19 is still raging around the world. However, so far there is no clinical evidence that any drug is effective for COVID-19 patients. Remdesivir is one of many coronavirus treatment […]

The past and present of coronavirus

The past and present of coronavirus

Most of us are infected with coronavirus at least once in our lives. This may be a worrying fact for many people, especially those who have only heard of the […]

Nat Med: disaster comes from the nose! SARS-CoV-2 can invade the body through key nasal cells!

Nat Med: disaster comes from the nose! SARS-CoV-2 can invade the body through key nasal cells!

Two special cell types in the nose have been identified as possible initial infection sites of COVID-19 coronavirus. Scientists have found that goblet cells and ciliated cells in the nose […]

Carbomer

Carbomer

Carbomer is a kind of polymer formed by chemical cross-linking of acrylic acid or acrylate with allyl ether, including polyacrylic acid (homopolymer) and long-chain alkyl alcohol acrylate polymer (copolymer). Its molecular […]

Will small molecular drugs be the “savior” of SARS-CoV-2?

Will small molecular drugs be the “savior” of SARS-CoV-2?

A novel coronavirus called SARS-CoV-2 (previously known as 2019-nCoV) is spreading widely and rapidly around the world. The disease of SARS-CoV-2 infection is termed Coronavirus Disease 2019 (COVID-19) by WHO. […]

Heavy news for diabetes! Johnson & Johnson Invokana approved for use in patients with type 2 diabetes and diabetic nephropathy

Heavy news for diabetes! Johnson & Johnson Invokana approved for use in patients with type 2 diabetes and diabetic nephropathy

Johnson & Johnson (JNJ) ‘s Janssen Pharmaceuticals has announced that Health Canada has approved a new indication for the glucose-lowering drug Invokana (canagliflozin): Complementary drugs for standard care therapies for […]

Nat Commun: New method may help study pathogenesis of Parkinson’s disease

Nat Commun: New method may help study pathogenesis of Parkinson’s disease

NMDARs (N-methyl-D-aspartate receptors) can act as valves for nerve cells and control the flow of electrical signals in the brain. This particular class of receptors is suspected of being present […]

Lilly’s RET inhibitor LOXO-292 receives FDA priority review

Lilly’s RET inhibitor LOXO-292 receives FDA priority review

Lilly recently announced that its RET inhibitor, selpercatinib (loxo-292), has been granted priority review status by the U.S. FDA and is expected to accelerate its approval for the treatment of […]

Nat Commun: SKP2 inhibitors such as niclosamide reduce MERS-CoV coronavirus replication in vitro by up to 28,000 times

Nat Commun: SKP2 inhibitors such as niclosamide reduce MERS-CoV coronavirus replication in vitro by up to 28,000 times

The Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) was first discovered in 2012 and can cause severe or even fatal pneumonia. There is currently no effective treatment for MERS-CoV. In […]